Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002728 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Heejin Jun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Receptors, Nicotinic, Liver, Signal Transduction, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIDDK NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH) is the progressive form of liver steatosis, the most common liver disease, and substantially increases the mortality rate. However, limited therapies are currently available to prevent MASH development. Identifying potential pharmacological treatments for the condition has been hampered by its heterogeneous and complex nature. Here, we identified a hepatic nonneuronal cholinergic signaling pathway required for metabolic adaptation to caloric overload. We found that cholinergic receptor nicotinic alpha 2 subunit (CHRNA2) is highly expressed in hepatocytes of mice and humans. Further, CHRNA2 is activated by a subpopulation of local acetylcholine-producing macrophages during MASH development. The activation of CHRNA2 coordinates defensive programs against a broad spectrum of MASH-related pathogenesis, including steatosis, inflammation, and fibrosis. Hepatocyte-specific loss of CHRNA2 signaling accelerates the disease onset in different MASH mouse models. Activation of this pathway via pharmacological inhibition of acetylcholine degradation protects against MASH development. Our study uncovers a hepatic nicotinic cholinergic receptor pathway that constitutes a cell-autonomous self-defense route against prolonged metabolic stress and holds therapeutic potential for combatting human MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
- Department of Nutritional Sciences, College of Human Sciences, Texas Tech University, Lubbock, Texas, United States of America.
- Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, China.
- International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, and College of Life Sciences and Technology, and Huazhong University of Science and Technology, Wu…
- Department of Chemistry, University of Michigan, Ann Arbor, Michigan, United States of America.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Jun Wu
Förderung
- NIAAA NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- NIGMS NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
- National Science Foundation
Zitieren
APA
Jun, H., Liu, S., Knights, A. J., Zhu, K., Ma, Y., Gong, J., Lenhart, A. E., Peng, X., Huang, Y., Ginder, J. P., Downie, C. H., Ramos, E. T., Kullander, K., Kennedy, R. T., Xu, X. Z. S., & Wu, J. (2024). Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002728
Vancouver
Jun H, Liu S, Knights AJ, Zhu K, Ma Y, Gong J, et al. Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002728
BibTeX
@article{Jun2024,
author = {Jun, Heejin and Liu, Shanshan and Knights, Alexander J and Zhu, Kezhou and Ma, Yingxu and Gong, Jianke and Lenhart, Ashley E and Peng, Xiaoling and Huang, Yunying and Ginder, Jared P and Downie, Christopher H and Ramos, Erika Thalia and Kullander, Klas and Kennedy, Robert T and Xu, X Z Shawn and Wu, Jun},
title = {Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002728}
}
EUVIMED